These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11824432)

  • 21. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of the acute alcohol withdrawal syndrome.
    Coleman JH; Evans WE
    Dis Nerv Syst; 1975 Apr; 36(4):151-4. PubMed ID: 234826
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative double-blind study of atrium 300 and hemineurine in chronic alcoholics (author's transl)].
    Teijeiro J
    Schweiz Rundsch Med Prax; 1976 Apr; 65(14):420-2. PubMed ID: 981161
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)].
    Delchier JC; Métreau JM; Lévy VG; Opolon P; Dhumeaux D
    Nouv Presse Med; 1979 Oct; 8(37):2955-8. PubMed ID: 503828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structure of the liver after correction of experimental chronic hepatitis with benzonal and potassium orotate].
    Baĭbekova EM; Sultanova LI
    Arkh Anat Gistol Embriol; 1990 Feb; 98(2):88-94. PubMed ID: 2353891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sedatives and liver diseases].
    Franken FH
    Dtsch Med Wochenschr; 1972 Mar; 97(11):433-4. PubMed ID: 5014564
    [No Abstract]   [Full Text] [Related]  

  • 29. [When drug withdrawal for safety concerns may be harmful. A case report with tetrabamate].
    Raveloarimisy L; Gras-Champel V; Lemaire-Nanni E; Burde-Hamm F; Andréjak M; Guilbaud JC
    Therapie; 2002; 57(6):593-5. PubMed ID: 12666269
    [No Abstract]   [Full Text] [Related]  

  • 30. [Double-blind study of the psycho-sedative effects of atrium 300 and chlorprothixene by alcoholics (author's transl)].
    Burner M; Caponi A
    Schweiz Rundsch Med Prax; 1978 May; 67(22):839-42. PubMed ID: 565928
    [No Abstract]   [Full Text] [Related]  

  • 31. [The medical treatment of the alcoholic--it's value and importance, shown with Atrium (author's transl)].
    Ladewig D
    Schweiz Rundsch Med Prax; 1980 Nov; 69(45):1671-4. PubMed ID: 7255328
    [No Abstract]   [Full Text] [Related]  

  • 32. Action from the CRM: barbiturates.
    Drug Ther Bull; 1980 Feb; 18(3):9-11. PubMed ID: 7353482
    [No Abstract]   [Full Text] [Related]  

  • 33. Why do migraineurs abuse butalbital-containing combination analgesics?
    Evans RW; Baskin SM
    Headache; 2010 Jul; 50(7):1194-7. PubMed ID: 20649651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cholestatic hepatitis caused by quinidine phenylethylbarbiturate, and sarcoidosis. Apropos of a case].
    Alix M; Mosquet B; Adrien A; Cuny G; Raffy P; Moulin M
    Therapie; 1989; 44(1):69. PubMed ID: 2734725
    [No Abstract]   [Full Text] [Related]  

  • 35. Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability.
    Huber B; Bocchicchio M; Hauser I; Horstmann V; Jokeit G; May T; Meinert T; Robertson E; Schorlemmer H; Schulz L; Wagner W; Seidel M
    Seizure; 2009 Mar; 18(2):109-18. PubMed ID: 18760938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse hepatitis effects and imputability (author's transl)].
    Albin H; Pere JC; Begaud B; Dangoumau J
    Therapie; 1981; 36(4):477-82. PubMed ID: 7292432
    [No Abstract]   [Full Text] [Related]  

  • 37. [Severe hepatitis caused by phenobarbital].
    Di Martino V; Mallat A; Duvoux C; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1994; 18(10):904-5. PubMed ID: 7875406
    [No Abstract]   [Full Text] [Related]  

  • 38. [New aspects of drug hepatotoxicity].
    Denjean P; Nouel O; N'Guyen JM; Beneton C; Allain H
    Ann Gastroenterol Hepatol (Paris); 1990 Dec; 26(7):293-8. PubMed ID: 2082807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lumiracoxib taken off the market in Australia. What does that mean for our patients? (interview by Dr. Judith Neumaier)].
    Brune K
    MMW Fortschr Med; 2007 Sep; 149(39):6. PubMed ID: 17987737
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.